Prostate Cancer - Results from #22860

Plasma-seq: A novel strategy for metastatic prostate cancer analysis - Abstract June 24, 2013

Treatment of local-regional prostate cancer detected by PSA screening: Benefits and harms according to prognostic factors - Abstract June 24, 2013

Coffee consumption and the risk of prostate cancer: The Ohsaki Cohort Study - Abstract June 24, 2013

MR imaging of prostate cancer in radiation oncology: What radiologists need to know - Abstract June 24, 2013

Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: Is immunosuppression to blame? - Abstract June 24, 2013

A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy - Abstract June 24, 2013

Outcome of radical prostatectomy in patients meeting criteria for active surveillance - Abstract June 24, 2013

Does periprostatic block increase the transrectal ultrasound (TRUS) biopsy sepsis rate in men with elevated PSA? - Abstract June 24, 2013

Perspectives on treatment of metastatic castration-resistant prostate cancer - Abstract June 21, 2013

Reducing rectal injury during external beam radiotherapy for prostate cancer - Abstract June 21, 2013

Agent Orange as a risk factor for high-grade prostate cancer - Abstract June 21, 2013

Role of (18)F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer - Abstract June 21, 2013

Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer - Abstract June 21, 2013

Canadian prostate brachytherapy in 2012 - Abstract June 21, 2013

Clinical significance of suboptimal hormonal levels in men with prostate cancer treated with LHRH agonists - Abstract June 21, 2013

Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system? - Abstract June 21, 2013

Metastatic prostate cancer with malignant ascites: A case report and literature review - Abstract June 21, 2013

A current perspective on the use of genomics in the diagnosis and treatment of prostate cancer, an interview with Stephen J. Freedland, MD June 21, 2013

Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy, by Stephen J. Freedland, MD June 21, 2013

AUA 2013 - Poster: Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy June 21, 2013

Page 1144 of 1435